Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FV9W7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,409
Award facts
- Contract value 100% obligated
- $18,409.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pens with a ceiling value of $18,409.30. This is a firm fixed-price delivery order with no set-aside designation, executed under a competitive award process. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 28, 2025. This delivery order is a child contract issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement through its comprehensive IDC with the Defense Logistics Agency. The parent contract functions as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of medications and medical supplies to support military healthcare programs worldwide, including serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Zepbound, a GLP-1 receptor agonist medication for diabetes management, represents the type of specialty pharmaceutical product included within the company's broad therapeutic portfolio available under its DLA contract vehicle.
Quick answers
Who was awarded contract SPE2DB25FV9W7?
SPE2DB25FV9W7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 27, 2025.
How much is contract SPE2DB25FV9W7 worth?
The government has obligated $18,409 on SPE2DB25FV9W7.
Is contract SPE2DB25FV9W7 an order under another contract?
Yes. SPE2DB25FV9W7 is a delivery order under SPE2DB20D3104, an indefinite delivery contract.
Was contract SPE2DB25FV9W7 competed?
The extent of competition for SPE2DB25FV9W7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award